RENNOVA HEALTH, INC. (NASDAQ:RNVA) Files An 8-K Material Modification to Rights of Security Holders

Item 3.03. Material Modification to Rights of Security Holders.

The information set forth in Item 5.03 is incorporated herein by
reference.

Item 5.03. Amendments to Articles of Incorporation or
Bylaws; Change in Fiscal Year.

On February 22, 2017, Rennova Health, Inc. (the Company) filed an
Amendment to its Certificate of Incorporation in order to effect
a 1-for-30 reverse stock split of the Companys shares of common
stock effective on February 22, 2017. As previously announced, on
December 22, 2016, the stockholders of the Company approved an
amendment to the Companys Certificate of Incorporation to effect
a reverse split of all of the Companys shares of common stock at
a specific ratio within a range from 1-for-10 to 1-for-30, and
granted authorization to the Board of Directors to determine in
its discretion the specific ratio and timing of the reverse split
prior to December 31, 2017. The Board approved the specific ratio
and timing on February 7, 2017.

As a result of the reverse stock split, every 30 shares of the
Companys pre-reverse split common stock have been combined and
reclassified into one share of the Companys common stock.
Proportionate voting rights and other rights of common
stockholders were not affected by the reverse stock split, other
than as a result of the rounding up of fractional shares.
Stockholders who would otherwise hold a fractional share of
common stock will receive an increase to their common stock as
the common stock will be rounded up to a full share. No
fractional shares will be issued in connection with the reverse
stock split.

The reverse stock split became effective at 5:00 pm, Eastern
Time, on February 22, 2017 and the Companys common stock
continued to trade on the NASDAQ Capital Market on a post-split
basis at the open of business on February 23, 2017. The Companys
post-reverse split common stock has a new CUSIP number:
759757602, but the par value and other terms of the common stock
will not be affected by the reverse stock split.

All outstanding preferred shares, stock options, warrants and
equity incentive plans immediately prior to the reverse stock
split have been appropriately adjusted by dividing the number of
shares of common stock into which the preferred shares, stock
options, warrants and equity incentive plans are exercisable or
convertible by 30 and multiplying the exercise or conversion
price by 30, as a result of the reverse stock split.

The Companys transfer agent, Computershare Inc., is acting as
exchange agent for the reverse stock split and will send
instructions to stockholders of record regarding the exchange of
certificates for common stock.

Item9.01. Financial Statements and Exhibits.

About RENNOVA HEALTH, INC. (NASDAQ:RNVA)

Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.

RENNOVA HEALTH, INC. (NASDAQ:RNVA) Recent Trading Information

RENNOVA HEALTH, INC. (NASDAQ:RNVA) closed its last trading session down -0.25 at 1.98 with 1,026,839 shares trading hands.